Skip to main content
. 2018 Jun 15;97(24):e10897. doi: 10.1097/MD.0000000000010897

Table 1.

Monthly laboratory assessment and SCORAD during omalizumab therapy in a case of severe, refractory atopic dermatitis.

2.